Tags: adjuvants, biochemistry, bioengineering, immune response, immunology, vaccine design, yeastalectiniblung canceradjuvantchemotherapy
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom | ||
2 | Elie Dolgin Nature Science journalist.
Writes for eliedolgin.com. Somerville, Massachusetts | Stealthy stem cells to treat disease - about 1 year ago | |
3 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
4 | Judy George MedPage Today Medical reporter, writer. | ||
5 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | New Frontiers in Vaccine Development - 3 months ago | |
6 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
7 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | Pharma takes aim at a wily foe — the Epstein-Barr virus - 4 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 6 months ago | |
8 | Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto | A Neural Thermostat Sets the Intensity of Immune Responses - 4 months ago To Boldly Go Where No Squid Has Gone Before - over 1 year ago | |
9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 7 months ago 4 offbeat biotechs making a splash in the life sciences - 10 months ago | |
10 | Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile | Protein power: a biotech mining viruses to fight disease - 8 months ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago |